Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCHEDULE: Everolimus with Early CNI Avoidance in Heart Transplant
NCT01266148Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of everolimus in heart transplantation, sponsored by Novartis. Started Nov 2009; status: completed.
02
Drugs
everolimus
03
Conditions
heart transplantation
Beyond the preview
Go deeper on NCT01266148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266148.